Shockwave Medical (NASDAQ:SWAV) Research Coverage Started at

Investment analysts at CL King started coverage on shares of Shockwave Medical (NASDAQ:SWAV – Get Free Report) in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm set a “buy” rating and a $368.00 price target on the stock. CL King’s target price suggests a potential upside of 16.43% from […]

Related Keywords

United States , Wellington , New Zealand General , New Zealand , Trinh Phung , Douglas Evan Godshall , Piper Sandler , Morgan Stanley , Vanguard Group Inc , Shockwave Medical Inc , Artisan Partners Limited Partnership , Securities Exchange Commission , Wellington Management Group , Nasdaq , Wells Fargo Company , Needham Company , Invesco Ltd , Shockwave Medical , Get Free Report , Evan Godshall , Exchange Commission , Management Group , Partners Limited Partnership , Shockwave Medical Daily , Nasdaq Swav , Swav , Medical , Initiated Coverage , Cl King ,